A new research paper reveals severe adverse effects including declining mental health, increased depression, self-harm, and suicide ideation among trans and non-binary young people and their parents following the UK puberty blocker ban Continue Reading The UK Puberty Blocker Ban: Evidence Reveals Widespread Harm to Transgender Children
TransLucent’s position statement argues against the ban on puberty blockers (GnRH analogues) for young trans people, citing insufficient evidence and potential bias in the Cass Review. Continue Reading TransLucent Puberty Blocker (GnRH Analogues) Position Statement
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.